Free Trial

Crescent Capital BDC (CCAP) Competitors

Crescent Capital BDC logo
$14.77 +0.01 (+0.07%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$14.74 -0.03 (-0.17%)
As of 07/25/2025 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CCAP vs. MFIC, BCSF, GSBD, AOD, AGD, AWP, THQ, THW, AVK, and AFB

Should you be buying Crescent Capital BDC stock or one of its competitors? The main competitors of Crescent Capital BDC include MidCap Financial Investment (MFIC), Bain Capital Specialty Finance (BCSF), Goldman Sachs BDC (GSBD), Aberdeen Total Dynamic Dividend Fund (AOD), Abrdn Global Dynamic Dividend Fund (AGD), abrdn Global Premier Properties Fund (AWP), Abrdn Healthcare Opportunities Fund (THQ), Abrdn World Healthcare Fund (THW), Advent Convertible and Income Fund (AVK), and AllianceBernstein National Municipal Income Fund (AFB). These companies are all part of the "financial services" industry.

Crescent Capital BDC vs. Its Competitors

MidCap Financial Investment (NASDAQ:MFIC) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

MidCap Financial Investment pays an annual dividend of $1.52 per share and has a dividend yield of 11.7%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 11.4%. MidCap Financial Investment pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 125.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years. MidCap Financial Investment is clearly the better dividend stock, given its higher yield and lower payout ratio.

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. MidCap Financial Investment is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MidCap Financial Investment$301.78M4.03$98.82M$1.2410.51
Crescent Capital BDC$60.50M9.05$73.65M$1.3411.02

MidCap Financial Investment has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Crescent Capital BDC has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500.

MidCap Financial Investment has a net margin of 33.21% compared to Crescent Capital BDC's net margin of 26.20%. Crescent Capital BDC's return on equity of 11.10% beat MidCap Financial Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
MidCap Financial Investment33.21% 10.66% 4.52%
Crescent Capital BDC 26.20%11.10%4.96%

In the previous week, MidCap Financial Investment had 3 more articles in the media than Crescent Capital BDC. MarketBeat recorded 5 mentions for MidCap Financial Investment and 2 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 1.93 beat MidCap Financial Investment's score of 0.58 indicating that Crescent Capital BDC is being referred to more favorably in the news media.

Company Overall Sentiment
MidCap Financial Investment Positive
Crescent Capital BDC Very Positive

28.5% of MidCap Financial Investment shares are owned by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.8% of MidCap Financial Investment shares are owned by company insiders. Comparatively, 1.1% of Crescent Capital BDC shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

MidCap Financial Investment presently has a consensus target price of $13.50, suggesting a potential upside of 3.61%. Crescent Capital BDC has a consensus target price of $17.60, suggesting a potential upside of 19.16%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than MidCap Financial Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MidCap Financial Investment
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Crescent Capital BDC
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

Crescent Capital BDC beats MidCap Financial Investment on 12 of the 19 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCAP vs. The Competition

MetricCrescent Capital BDCFIN IndustryFinance SectorNASDAQ Exchange
Market Cap$547.01M$1.62B$12.28B$9.50B
Dividend Yield11.20%10.79%5.55%4.01%
P/E Ratio11.0217.5619.0320.06
Price / Sales9.0558.8726.0989.33
Price / Cash6.6311.6221.6358.56
Price / Book0.740.962.205.87
Net Income$73.65M$144.88M$997.25M$258.55M
7 Day Performance1.93%-0.39%0.60%3.73%
1 Month Performance1.44%3.73%3.44%11.75%
1 Year Performance-21.10%-5.21%536.57%18.02%

Crescent Capital BDC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCAP
Crescent Capital BDC
2.9484 of 5 stars
$14.77
+0.1%
$17.60
+19.2%
-20.7%$547.01M$60.50M11.02N/APositive News
Analyst Upgrade
MFIC
MidCap Financial Investment
2.0277 of 5 stars
$13.11
-1.1%
$14.00
+6.8%
-8.7%$1.24B$301.78M10.57N/AAnalyst Downgrade
BCSF
Bain Capital Specialty Finance
1.948 of 5 stars
$15.17
-2.3%
$16.50
+8.8%
-7.6%$1.01B$292.65M8.721,000Positive News
GSBD
Goldman Sachs BDC
1.2097 of 5 stars
$11.63
-2.1%
$12.00
+3.2%
-20.4%$1.39B$434.37M25.83N/APositive News
AOD
Aberdeen Total Dynamic Dividend Fund
N/A$9.04
+0.7%
N/A+8.0%$0.00$94.38M0.00N/A
AGD
Abrdn Global Dynamic Dividend Fund
N/A$11.30
+0.6%
N/A+17.4%$0.00$25.50M0.00N/A
AWP
abrdn Global Premier Properties Fund
N/A$3.85
+1.5%
N/A-4.9%$0.00$45.21M0.00N/APositive News
High Trading Volume
THQ
Abrdn Healthcare Opportunities Fund
N/A$16.96
-1.5%
N/A-19.5%$0.00$6.59M0.001,088High Trading Volume
THW
Abrdn World Healthcare Fund
N/A$10.17
-2.7%
N/A-13.3%$0.00$2.90M0.00N/A
AVK
Advent Convertible and Income Fund
N/A$12.25
-0.9%
N/A-1.2%$0.00$51.89M0.00N/A
AFB
AllianceBernstein National Municipal Income Fund
N/A$10.13
+0.1%
N/A-9.0%$0.00$602.34K0.00N/A

Related Companies and Tools


This page (NASDAQ:CCAP) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners